(NASDAQ: MDLN) Medline's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 13.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,548.38%.
Medline's revenue in 2026 is N/A.On average, 24 Wall Street analysts forecast MDLN's revenue for 2026 to be $57,435,044,416,596, with the lowest MDLN revenue forecast at $54,454,924,187,433, and the highest MDLN revenue forecast at $59,947,044,337,653.
In 2027, MDLN is forecast to generate $61,769,764,749,924 in revenue, with the lowest revenue forecast at $58,424,731,839,639 and the highest revenue forecast at $65,352,543,800,940.